{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:03:54Z","timestamp":1790143434755,"version":"4.0.1"},"reference-count":25,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inherited pyrimidine 5\u2032-nucleotidase type I (P5\u2032N-1) deficiency is the third most common erythrocyte enzymopathy that causes hemolysis. Fourteen different mutations have been identified to date. We have investigated the molecular bases of the disease by studying the biochemical properties of the recombinant wild-type human enzyme and 4 variant proteins (D87V, L131P, N179S, and G230R) bearing missense mutations found in patients affected by nonspherocytic hemolytic anemia. P5\u2032N-1 is a relatively stable protein and has essentially identical catalytic efficiency toward cytidine monophosphate (CMP) and uridine monophosphate (UMP). All investigated mutant proteins display impaired catalytic properties and\/or reduced thermostability, providing a rationale for the pathological effects of the mutations. Despite the substantial changes in the kinetic and thermostability parameters, the enzyme activity detected in the red blood cells of patients homozygous for mutations L131P and G230R exhibits moderate alterations. This suggests that P5\u2032N-1 deficiency is compensated, possibly by other nucleotidases or alternative pathways in nucleotide metabolism. Therefore, nucleotidase activity may not be considered a prognostic indicator in patients affected by the enzymopathy. (Blood. 2005;105:3340-3345)<\/jats:p>","DOI":"10.1182\/blood-2004-10-3895","type":"journal-article","created":{"date-parts":[[2004,12,17]],"date-time":"2004-12-17T01:24:44Z","timestamp":1103246684000},"page":"3340-3345","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Functional analysis of pyrimidine 5\u2032-nucleotidase mutants causing nonspherocytic hemolytic anemia"],"prefix":"10.1182","volume":"105","author":[{"given":"Laurent R.","family":"Chiarelli","sequence":"first","affiliation":[{"name":"From the Department of Biochemistry \u201cA. Castellani,\u201d University of Pavia, Italy; Department of Genetics and Microbiology \u201cA. Buzzati-Traverso,\u201d University of Pavia, Italy; and Hematology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bianchi","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry \u201cA. Castellani,\u201d University of Pavia, Italy; Department of Genetics and Microbiology \u201cA. Buzzati-Traverso,\u201d University of Pavia, Italy; and Hematology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Fermo","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry \u201cA. Castellani,\u201d University of Pavia, Italy; Department of Genetics and Microbiology \u201cA. Buzzati-Traverso,\u201d University of Pavia, Italy; and Hematology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Galizzi","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry \u201cA. Castellani,\u201d University of Pavia, Italy; Department of Genetics and Microbiology \u201cA. Buzzati-Traverso,\u201d University of Pavia, Italy; and Hematology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Iadarola","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry \u201cA. Castellani,\u201d University of Pavia, Italy; Department of Genetics and Microbiology \u201cA. Buzzati-Traverso,\u201d University of Pavia, Italy; and Hematology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mattevi","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry \u201cA. Castellani,\u201d University of Pavia, Italy; Department of Genetics and Microbiology \u201cA. Buzzati-Traverso,\u201d University of Pavia, Italy; and Hematology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zanella","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry \u201cA. Castellani,\u201d University of Pavia, Italy; Department of Genetics and Microbiology \u201cA. Buzzati-Traverso,\u201d University of Pavia, Italy; and Hematology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Valentini","sequence":"additional","affiliation":[{"name":"From the Department of Biochemistry \u201cA. Castellani,\u201d University of Pavia, Italy; Department of Genetics and Microbiology \u201cA. Buzzati-Traverso,\u201d University of Pavia, Italy; and Hematology Division, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Maggiore, Milano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218551288900_REF1","doi-asserted-by":"crossref","unstructured":"Bianchi V, Spychala J. Mammalian 5\u2032-nucleotidases. J Biol Chem. 2003;278: 46195-46198.","DOI":"10.1074\/jbc.R300032200"},{"key":"2020021218551288900_REF2","doi-asserted-by":"crossref","unstructured":"Rees DC, Duley JA, Marinaki AM. Pyrimidine 5\u2032 nucleotidase deficiency. Br J Haematol. 2003;120: 375-383.","DOI":"10.1046\/j.1365-2141.2003.03980.x"},{"key":"2020021218551288900_REF3","doi-asserted-by":"crossref","unstructured":"Amici A, Emanuelli M, Magni G, Raffaelli N, Ruggieri S. Pyrimidine nucleotidases from human erythrocyte possess phosphotranspherase activities specific for pyrimidine nucleotides. FEBS Lett. 1997;419: 263-267.","DOI":"10.1016\/S0014-5793(97)01464-6"},{"key":"2020021218551288900_REF4","doi-asserted-by":"crossref","unstructured":"Amici A, Magni G. Human erythrocyte pyrimidine 5\u2032-nucleotidase, PN-I. Arch Biochem Biophys. 2002;397: 184-190.","DOI":"10.1006\/abbi.2001.2676"},{"key":"2020021218551288900_REF5","doi-asserted-by":"crossref","unstructured":"Marinaki AM, Escuredo E, Duley JA, et al. Genetic basis of hemolytic anemia caused by pyrimidine 5\u2032 nucleotidase deficiency. Blood2001;97: 3327-3332.","DOI":"10.1182\/blood.V97.11.3327"},{"key":"2020021218551288900_REF6","doi-asserted-by":"crossref","unstructured":"Amici A, Emanuelli M, Raffaelli N, Ruggieri S, Saccucci F, Magni G. Human erythrocyte pyrimidine 5\u2032-nucleotidase, PN-I, is identical to p36, a protein associated to lupus inclusion formation in response to alpha-interferon. Blood2000;96: 1596-1598.","DOI":"10.1182\/blood.V96.4.1596.h8001596_1596_1598"},{"key":"2020021218551288900_REF7","doi-asserted-by":"crossref","unstructured":"Kanno H, Takizawa T, Miwa S, Fujii H. Molecular basis of Japanese variants of pyrimidine 5\u2032-nucleotidase deficiency. Br J Haematol. 2004;126: 265-271.","DOI":"10.1111\/j.1365-2141.2004.05029.x"},{"key":"2020021218551288900_REF8","doi-asserted-by":"crossref","unstructured":"Valentine WN, Fink K, Paglia DE, Harris SR, Adams WS. Hereditary hemolytic anemia with human erythrocyte pyrimidine 5\u2032-nucleotidase deficiency. J Clin Invest. 1974;54: 866-879.","DOI":"10.1172\/JCI107826"},{"key":"2020021218551288900_REF9","doi-asserted-by":"crossref","unstructured":"Vives-Corrons JL. Chronic non-spherocytic haemolytic anaemia due to congenital pyrimidine 5\u2032 nucleotidase deficiency: 25 years later. Baillieres Best Pract Res Clin Haematol. 2000;13: 103-118.","DOI":"10.1053\/beha.1999.0060"},{"key":"2020021218551288900_REF10","doi-asserted-by":"crossref","unstructured":"Hirono A, Forman L, Beutler E. Enzymatic diagnosis in non-spherocytic hemolytic anemia. Medicine (Baltimore). 1988;67: 110-117.","DOI":"10.1097\/00005792-198803000-00004"},{"key":"2020021218551288900_REF11","doi-asserted-by":"crossref","unstructured":"Bianchi P, Fermo E, Alfinito F, et al. Molecular characterization of six unrelated Italian patients affected by pyrimidine 5\u2032-nucleotidase deficiency. Br J Haematol. 2003;122: 847-851.","DOI":"10.1046\/j.1365-2141.2003.04532.x"},{"key":"2020021218551288900_REF12","doi-asserted-by":"crossref","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193: 265-275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"2020021218551288900_REF13","doi-asserted-by":"crossref","unstructured":"Amici A, Emanuelli M, Raffaelli N, Ruggieri S, Magni G. One-minute high-performance liquid chromatography assay for 5\u2032-nucleotidase using a 20-mm reverse-phase column. Anal Biochem. 1994;216: 171-175.","DOI":"10.1006\/abio.1994.1022"},{"key":"2020021218551288900_REF14","doi-asserted-by":"crossref","unstructured":"Andrade MA, Chaco\u0301n P, Merelo JJ, Mora\u0301n F. Evaluation of secondary structure of proteins from UV circular dichroism using an unsupervised learning neural network. Protein Eng. 1993;6: 383-390.","DOI":"10.1093\/protein\/6.4.383"},{"key":"2020021218551288900_REF15","doi-asserted-by":"crossref","unstructured":"Miwa S, Fujii H. Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes. Am J Hematol. 1996;51: 122-132.","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<122::AID-AJH5>3.0.CO;2-#"},{"key":"2020021218551288900_REF16","doi-asserted-by":"crossref","unstructured":"Jacobasch G. Biochemical and genetic basis of red cell enzyme deficiencies. Baillieres Best Pract Res Clin Haematol. 2000;13: 1-20.","DOI":"10.1053\/beha.2000.0054"},{"key":"2020021218551288900_REF17","doi-asserted-by":"crossref","unstructured":"Beutler E, Barnako PV, Feadler J, et al. Hemolytic anemia due to pyrimidine 5\u2032 nucleotidase deficiency: report of eight cases in six families. Blood. 1980;56: 251-255.","DOI":"10.1182\/blood.V56.2.251.251"},{"key":"2020021218551288900_REF18","doi-asserted-by":"crossref","unstructured":"Wang C, Chiarelli LR, Bianchi P, et al. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia. Blood. 2001;98: 3113-3120.","DOI":"10.1182\/blood.V98.10.3113"},{"key":"2020021218551288900_REF19","doi-asserted-by":"crossref","unstructured":"Valentini G, Chiarelli LR, Fortin R, et al. Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia. J Biol Chem. 2002;277: 23807-23814.","DOI":"10.1074\/jbc.M202107200"},{"key":"2020021218551288900_REF20","doi-asserted-by":"crossref","unstructured":"Mass M, Simo E, Dragon S. Erythroid pyrimidine 5\u2032-nucleotidase: cloning, developmental expression, and regulation by cAMP and in vivo hypoxia. Blood. 2003;102: 4198-4205.","DOI":"10.1182\/blood-2002-11-3388"},{"key":"2020021218551288900_REF21","doi-asserted-by":"crossref","unstructured":"Balta G, Gumruk F, Akarsu N, Gurgey A, Altay C. Molecular characterization of Turkish patients with pyrimidine 5\u2032 nucleotidase-I deficiency. Blood. 2003;102: 1900-1903.","DOI":"10.1182\/blood-2003-02-0628"},{"key":"2020021218551288900_REF22","doi-asserted-by":"crossref","unstructured":"Hirono A, Fujii H, Natori H, Kurokawa I, Miwa S. Chromatographic analysis of human erythrocyte pyrimidine 5\u2032-nucleotidase from five patients with pyrimidine 5\u2032-nucleotidase deficiency. Br J Haematol. 1987;65: 35-41.","DOI":"10.1111\/j.1365-2141.1987.tb06132.x"},{"key":"2020021218551288900_REF23","doi-asserted-by":"crossref","unstructured":"Rampazzo C, Johansson M, Gallinaro L, et al. Mammalian 5\u2032(3\u2032)-deoxyribonucleotidase, cDNA cloning, and overexpression of the enzyme in Escherichia coli and mammalian cells. J Biol Chem. 2000;275: 5409-5415.","DOI":"10.1074\/jbc.275.8.5409"},{"key":"2020021218551288900_REF24","doi-asserted-by":"crossref","unstructured":"Beutler E, West C. Tissue distribution of pyrimidine-5\u2032-nucleotidase. Biochem Med. 1982;27: 334-341.","DOI":"10.1016\/0006-2944(82)90038-2"},{"key":"2020021218551288900_REF25","doi-asserted-by":"crossref","unstructured":"Shinohara K, Tanaka KR. Kinetic and electrophoretic studies of human erythrocytes deficient in pyrimidine 5\u2032-nucleotidase. Hum Genet. 1979;51: 107-111.","DOI":"10.1007\/BF00278299"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/8\/3340\/1709215\/zh800805003340.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/8\/3340\/1709215\/zh800805003340.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T18:11:29Z","timestamp":1625163089000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/8\/3340\/20568\/Functional-analysis-of-pyrimidine-5nucleotidase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,15]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-10-3895","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,15]]}}}